Research - Harrington Park, New Jersey, United States
• Immucrine Biopharma Consulting provides scientific and business expertise with start-up biotech companies in drug discovery/development of immunology- & inflammation-based therapeutics, especially those for autoimmune diseases with emphasis on type 1 diabetes• Its leadership has two decades of experience and success in the biopharma industry and academic research environments that includes an extensive network of first-hand professional relationships with key opinion leaders• Immucrine works with its clients to help create therapeutic development and business plans suitable for generating investment funds, in addition to utilizing its strong connections and relationships with investors in the pharmaceutical industry who are actively scouting for exciting innovation. These goals are accomplished to for clients by: - constructing Value Propositions that support a practical goal-oriented plan - establishing Therapeutic Development Strategic and Tactical Plan (therapeutic rationale, preclinical structure, clinical progression) - developing Business Plan including financials, management design, value inflection timeline - developing and executing Funding Strategy (e.g., facilitate clinical support from consortia) - creating and presenting Investment Pitch Decks with company/client management to funding organizations - Non-dilutive financing: Preparing grant proposals (NIH SBIR and foundation grants)